Close Menu
    Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biosecurity

    WHO Updates Blueprint List of Priority Diseases

    By Global Biodefense StaffFebruary 12, 2018
    Priority Pathogens Blueprint
    Share
    Facebook LinkedIn Reddit Email

    The 2018 review of the World Health Organization’s Blueprint list of priority diseases occurred February 6-7, 2018. Given their potential to cause a public health emergency and the absence of efficacious medical countermeasures, there is an urgent need for accelerated research and development for:

    • Crimean-Congo haemorrhagic fever (CCHF)
    • Ebola virus disease and Marburg virus disease
    • Lassa fever
    • Middle East respiratory syndrome coronavirus (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS)
    • Nipah and henipaviral diseases
    • Rift Valley fever (RVF)
    • Zika
    • Disease X

    Disease X represents the knowledge that a serious international epidemic could be caused by a pathogen currently unknown to cause human disease, and so the R&D Blueprint explicitly seeks to enable cross-cutting R&D preparedness that is also relevant for an unknown “Disease X” as far as possible.

    A number of additional diseases were discussed and considered for inclusion in the priority list, including:

    • Arenaviral hemorrhagic fevers other than Lassa Fever
    • Chikungunya
    • highly pathogenic coronaviral diseases other than MERS and SARS
    • emergent non-polio enteroviruses (including EV71, D68)
    • Severe Fever with Thrombocytopenia Syndrome (SFTS)

    These diseases pose major public health risks and further research and development is needed, including surveillance and diagnostics. They should be watched carefully and considered again at the next annual review. Efforts in the interim to understand and mitigate them are encouraged.

    Although not included on the list of diseases to be considered at the meeting, monkeypox and leptospirosis were discussed and experts stressed the risks they pose to public health. There was agreement on the need for rapid evaluation of available potential countermeasures as well as the establishment of more comprehensive surveillance and diagnostics.

    Read more: WHO R&D Blueprint

    Arenavirus Chikungunya Crimean-Congo Disease X Ebola Emerging Threats Enterovirus D68 Leptospirosis Marburg MERS-CoV mpox Nipah Virus Poxviruses Rift Valley Fever SARS Zika
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleWMD Epigenetic CHaracterization and Observation (ECHO) Proposers Day
    Next Article Biodefense Headlines – February 12, 2018

    Related Stories

    Needle-Free Vaccine Patch Against Zika Virus

    December 2, 2023

    Ontario Supporting $165M Investment to Secure Critical PPE Supply

    December 2, 2023

    Valley Fever: An Invisible Killer Expands Its Range in the American West

    November 17, 2023

    Virginia Tech Lab Selected for National Partnership to Fight Emerging Diseases

    November 14, 2023
    News Scan

    Biodefense Headlines – 30 November 2023

    News Scan November 30, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the largest ever outbreak of mpox in the DRC; launch of National Wastewater Surveillance Program dashboard; low uptake of COVID-19 boosters and flu vaccines;…

    Upcoming Events

    Mar 12
    Hybrid Hybrid Event
    March 12, 2024 - March 17, 2024

    2024 Fungal Genetics Conference

    Mar 21
    March 21, 2024 - March 23, 2024

    ASPPH 2024 Annual Meeting

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    News on pathogens and preparedness for public health emergencies

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.